# Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

> **NCT01868126** · PHASE2 · COMPLETED · sponsor: **Santen Inc.** · enrollment: 91 (actual)

## Conditions studied

- Open-angle Glaucoma or Ocular Hypertension

## Interventions

- **DRUG:** DE-117 ophthalmic solution
- **DRUG:** latanoprost ophthalmic solution
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01868126
- **Lead sponsor:** Santen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01868126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01868126, "Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01868126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*